Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free BIO Stock Alerts $276.96 +1.01 (+0.37%) (As of 04/29/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 7After Market ClosesConfirmedActual EPS (Feb. 15) $3.10 Beat By $0.17 Consensus EPS (Feb. 15) $2.93 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Bio-Rad Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIIf you have $2,500 bucks… check this out This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! Click here to unlock the Income Glitch training workshop for free. Bio-Rad Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$2.06$2.06$2.06 Q2 20241$2.17$2.17$2.17 Q3 20241$2.80$2.80$2.80 Q4 20241$3.39$3.39$3.39 FY 20244$10.42$10.42$10.42 Q1 20251$2.39$2.39$2.39 Q2 20251$1.95$1.95$1.95 Q3 20251$3.83$3.83$3.83 Q4 20251$3.30$3.30$3.30 FY 20254$11.47$11.47$11.47 Q1 20261$2.84$2.84$2.84 BIO Earnings Date and InformationBio-Rad Laboratories last posted its quarterly earnings results on February 15th, 2024. The medical research company reported $3.10 EPS for the quarter, beating analysts' consensus estimates of $2.93 by $0.17. The firm earned $681.18 million during the quarter, compared to the consensus estimate of $685 million. Its quarterly revenue was down 6.7% on a year-over-year basis. Bio-Rad Laboratories has generated ($21.49) earnings per share over the last year (($21.49) diluted earnings per share). Earnings for Bio-Rad Laboratories are expected to grow by 10.09% in the coming year, from $10.41 to $11.46 per share. Bio-Rad Laboratories has confirmed that its next quarterly earnings report will be published on Tuesday, May 7th, 2024. Bio-Rad Laboratories will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call.. Read More Bio-Rad Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/7/2024Confirmed)------- 2/15/2024Q4 2023$2.93$3.10+$0.17($5.94)$685.00 million$681.18 million 10/26/2023Q3 2023$2.87$2.33($0.54)$1.02$689.50 million$632.10 million 8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96 million$681.10 million 5/4/2023Q1 2023$3.24$3.34+$0.10$4.36$689.28 million$676.80 million 2/16/2023Q4 2022$3.45$3.31($0.14)($21.16)$741.01 million$730.29 million 10/27/2022Q3 2022$2.59$2.60+$0.01$10.72$685.50 million$680.10 million Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 7/28/2022Q2 2022$2.46$3.38+$0.92$37.88$664.60 million$691.10 million 4/28/2022Q1 2022$2.80$4.94+$2.14$122.45$678.00 million$700.10 million 2/10/2022Q4 2021$2.87$3.21+$0.34$59.01$731.94 million$732.80 million 10/28/2021Q3 2021$2.30$3.71+$1.41($122.54)$670.36 million$747.00 million 7/28/2021Q2 2021$2.66$3.54+$0.88($23.24)$610.40 million$715.93 million 4/29/2021Q1 2021$2.50$5.21+$2.71($21.96)$661.00 million$726.80 million Bio-Rad Laboratories Earnings - Frequently Asked Questions When is Bio-Rad Laboratories's earnings date? Bio-Rad Laboratories has confirmed that its next quarterly earnings data will be published on Tuesday, May 7th, 2024. Learn more on BIO's earnings history. Did Bio-Rad Laboratories beat their earnings estimates last quarter? In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $3.10 earnings per share (EPS) to beat the analysts' consensus estimate of $2.93 by $0.17. Learn more on analysts' earnings estimate vs. BIO's actual earnings. How can I listen to Bio-Rad Laboratories's earnings conference call? The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Bio-Rad Laboratories's conference call transcript? The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript How can I view Bio-Rad Laboratories's earnings report? Bio-Rad Laboratories's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.67 billion. How much profit does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$637.32 million. BIO has generated -$21.49 earnings per share over the last four quarters. What is Bio-Rad Laboratories's EPS forecast for next year? Bio-Rad Laboratories's earnings are expected to grow from $10.41 per share to $11.46 per share in the next year, which is a 10.09% increase. More Earnings Resources from MarketBeat Related Companies: WAT Earnings ILMN Earnings BIO.B Earnings RVTY Earnings TXG Earnings OLK Earnings AVTR Earnings EHC Earnings PEN Earnings ASND Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:BIO) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI stock to buy right nowStockEarningsGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.